Cwm, LLC Moleculin Biotech, Inc. Transaction History

Cwm, LLC

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$1.64 - $2.83 $547 - $945	-334 Closed	0 $0
Q1 2021 Sep 15, 2021	BUY	$3.7 - $6.42 $1,235 - $2,144	334 New	334 $1,000
Q1 2021 Apr 27, 2021	SELL	$3.7 - $6.42 $1,235 - $2,144	-334 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$4.07 - $5.94 $1,359 - $1,983	334 New	334 $1,000
Q4 2020 Jan 27, 2021	SELL	$4.07 - $5.94 $1,359 - $1,983	-334 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$4.51 - $7.98 $1,506 - $2,665	334 New	334 $1,000
Q3 2020 Oct 19, 2020	SELL	$4.51 - $7.98 $1,506 - $2,665	-334 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$3.38 - $8.82 $1,128 - $2,945	334 New	334 $1,000
Q2 2020 Jul 22, 2020	SELL	$3.38 - $8.82 $1,128 - $2,945	-334 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$2.4 - $6.3 $801 - $2,104	334 New	334 $1,000
Q1 2020 Apr 28, 2020	SELL	$2.4 - $6.3 $801 - $2,104	-334 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$5.49 - $6.84 $1,833 - $2,284	334 New	334 $1,000
Q4 2019 Jan 27, 2020	SELL	$5.49 - $6.84 $1,833 - $2,284	-334 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$6.12 - $7.86 $2,044 - $2,625	334 New	334 $1,000
Q3 2019 Oct 22, 2019	SELL	$6.12 - $7.86 $2,044 - $2,625	-334 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$5.36 - $17.88 $1,790 - $5,971	334 New	334 $1,000
Q2 2019 Jul 31, 2019	SELL	$5.36 - $17.88 $1,790 - $5,971	-334 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$4.86 - $9.54 $1,623 - $3,186	334 New	334 $0

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $48.6M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.